Management of serious infections caused by metallo β-lactamases with or without OXA-48-like expressing Enterobacterales with aztreonam and ceftazidime/avibactam combination: Dosing strategy for better clinical outcome-Reference-Cited by-同舟云学术

Management of serious infections caused by metallo β-lactamases with or without OXA-48-like expressing Enterobacterales with aztreonam and ceftazidime/avibactam combination: Dosing strategy for better clinical outcome

Published:2021-04 Issue: Volume: Page:
ISSN:0255-0857
Container-title:Indian Journal of Medical Microbiology
language:en
Short-container-title:Indian Journal of Medical Microbiology

Author:

Veeraraghavan Balaji,Bakthavatchalam Yamuna Devi,Soman Rajeev,Swaminathan Subramanian,Manesh Abi,Nagvekar Vasanth,Nangia Vivek

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference13 articles.

1. Therapeutic options for metallo-β-lactamase-producing Enterobacterales;Tan;Infect Drug Resist,2021

2. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing Enterobacterales;Falcone;Open Forum Infect Dis,2020

3. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection;Shaw;J Antimicrob Chemother,2018

4. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience;Veeraraghavan;Pathog Glob Health,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a pentaplex PCR assay for rapid detection of blaCTX-M, blaOXA–1, blaCMY, blaNDM and the PBP3 insert in Enterobacterales;Indian Journal of Medical Microbiology;2024-11

2. Difficult to Treat Gram-Negative Bacteria—The Indian Scenario;Current Infectious Disease Reports;2024-01-20

3. Ceftazidime-avibactam/aztreonam combination synergy against carbapenem-resistant Gram-negative isolates: In vitro study;Current Medicine Research and Practice;2024-01

4. Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice;The Lancet Regional Health - Southeast Asia;2023-08

5. Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against Klebsiella pneumoniae by MALDI-TOF MS;Antibiotics;2023-06-16